express– The new therapy consists of antibody cocktails that could reduce severe illness in coronavirus patients, if administered within three days of contracting the deadly virus. The experimental treatment was developed by US company Regeneron Pharmaceuticals and was used to “cure” Donald Trump after he became infected with Covid last year. The company was granted an emergency licence for its drugs in the US, following the former US President’s rapid recovery.
Regeneron claims that its cocktail of antibodies reduces symptomatic infections among those sharing a household with someone ill with Covid by 100 percent.
The drugs are undergoing trials carried out by Oxford University and are expected to be approved for use later in the summer.
Sir Simon Stevens, hea
He told the NHS Confederation virtual conference on Tuesday: “We expect that we will begin to see further therapies that will actually treat coronavirus and prevent severe illness and death.
